Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Sage Therapeutics Inc. buy TD Cowen

Start price
€17.30
08.08.23 / 50%
Target price
€25.55
08.08.24
Performance (%)
-56.61%
End price
€7.51
09.08.24
Summary
This prediction ended on 09.08.24 with a price of €7.51. The BUY prediction by TD_Cowen for Sage Therapeutics Inc. performed very badly with a performance of -56.61%. TD_Cowen has 50% into this prediction
Performance without dividends (%)
Name 1w 1m 1y
Sage Therapeutics Inc. - - -
iShares Core DAX® 0.396% -0.010% 17.421%
iShares Nasdaq 100 0.881% -0.819% 7.914%
iShares Nikkei 225® 1.405% -3.232% 12.470%
iShares S&P 500 0.259% -0.051% 2.814%

Comments by TD_Cowen for this prediction

In the thread Sage Therapeutics Inc. diskutieren
Prediction Buy
Perf. (%) -56.61%
Target price 25.550
Change
Ends at 08.08.24

Sage Therapeutics, Inc. (NASDAQ: SAGE) had its price target lowered by analysts at TD Cowen from $105.00 to $28.00. They now have an "outperform" rating on the stock.
Ratings data for SAGE provided by MarketBeat

In the thread Trading Sage Therapeutics Inc.
Prediction Buy
Perf. (%) -56.61%
Target price 25.550
Change
Ends at 08.08.24

Die von TD_Cowen gewählte maximale Laufzeit wurde überschritten